Osaic Holdings
BCTX

Osaic Holdings’s Briacell Therapeutics BCTX Stock Holding History

Osaic Holdings’s Portfolio BCTX Stock Details BCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-72
Closed -$94 – 7865
2025
Q3 		$94 Buy
72
+65
+929% +$683 ﹤0.01% 7753
2025
Q2 		$194 Hold
7
– – ﹤0.01% 7505
2025
Q1 		$244 Hold
7
– – ﹤0.01% 7138
2024
Q4 		$581 Hold
7
– – ﹤0.01% 6987
2024
Q3 		$1.24K Hold
7
– – ﹤0.01% 6773
2024
Q2 		$1.17K Hold
7
– – ﹤0.01% 6768
2024
Q1 		$2.95K Buy
+7
New +$3.86K ﹤0.01% 6316
2023
Q4 		– Hold
0
– – – 7143
2023
Q3 		– Hold
0
– – – 7153
2023
Q2 		– Hold
0
– – – 7203
2023
Q1 		– Hold
0
– – – 7240
2022
Q4 		– Hold
0
– – – 7175
2022
Q3 		– Hold
0
– – – 7254
2022
Q2 		– Hold
0
– – – 7333
2022
Q1 		– Hold
0
– – – 7236
2021
Q4 		– Hold
0
– – – 7377
2021
Q3 		– Hold
0
– – – 7177
2021
Q2 		– Sell
-40
Closed -$24.9K – 6985
2021
Q1 		$23K Buy
+40
New +$21.8K ﹤0.01% 5380

Other funds holding BCTX

FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $266M AUM 24.57% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings's BCTX Position: Q4 2025 in Review

Osaic Holdings sold out of Briacell Therapeutics (BCTX) in Q4 2025, closing a stake of 72 shares — an estimated $94 sold.

Osaic Holdings first reported a position in BCTX in Q1 2021 and held it in 8 quarters. The position peaked at $23K in Q1 2021. 13 funds tracked by Wall St. Rank hold BCTX as of Q4 2025.

  • Osaic Holdings reported no remaining Briacell Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 72 Briacell Therapeutics shares in Q4 2025, an estimated $94.
  • Osaic Holdings first reported a position in Briacell Therapeutics in Q1 2021 and held it in 8 quarters.
  • Osaic Holdings's Briacell Therapeutics position peaked at $23K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Briacell Therapeutics as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.